Skip to main content
SpringerLink
Log in

Coagulation Management in Neurosurgical Critical Care

  • Chapter
  • First Online:
Book cover Essentials of Neurosurgical Anesthesia & Critical Care

  • 1558 Accesses

Abstract

Neurocritical care patients are at extremely high risk for complications related to hereditary or acquired coagulopathies, as well as venous thromboembolic complications. The benefits of pharmacologic prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) must be weighed against the risk of catastrophic intracranial or perispinal hemorrhage. This section focuses on the two most common coagulation management issues: (1) thromboembolic disease and (2) coagulopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066–78.

    Article  Google Scholar 

  • Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339:80–5.

    Article  CAS  Google Scholar 

  • Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002;105(12):1416–9.

    Article  Google Scholar 

  • Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonist. Chest. 2008;133:160S–98.

    Article  CAS  Google Scholar 

  • Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ. New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol. 2013;70:1486–90.

    PubMed  Google Scholar 

  • Crowther MA, Cook DJ, Griffith LE, et al. Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med. 2005;31:48–55.

    Article  CAS  Google Scholar 

  • De Manoel O, et al. The critical care management of spontaneous intracranial hemorrhage: a contemporary review. Crit Care. 2016;20:272.

    Article  Google Scholar 

  • De Monyé W, Sanson BJ, Mac Gillavry MR, et al. Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med. 2002;165:345–8.

    Article  Google Scholar 

  • Droubatchevskaia N, Wong WP, Chipperfield KM, Wadsworth LD, Ferguson DJ. Guidelines for cryoprecipitate transfusion.

    Google Scholar 

  • Frontera, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage; a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24:6–46.

    Article  CAS  Google Scholar 

  • Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335:701–7.

    Article  CAS  Google Scholar 

  • Goldstein JN, Greenberg SM. Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med. 2010;77(11):791–9.

    Article  Google Scholar 

  • Grove JR, Pevec WC. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000;11:837–40.

    Article  CAS  Google Scholar 

  • Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S–47S.

    Article  CAS  Google Scholar 

  • Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.

    Article  CAS  Google Scholar 

  • Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery. 1994;34:280–96.

    Article  CAS  Google Scholar 

  • Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke. 2005;36:1588–93.

    Article  Google Scholar 

  • Irem Baharoglu M, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605–13.

    Article  Google Scholar 

  • Joffe HV, Kucher N, Tapson V, et al. Upper-extremity deep vein thrombosis a prospective registry of 592 patients. Circulation. 2004;110:1605–11.

    Article  Google Scholar 

  • Karafin MS, Hilyer CD, Shaz BH. Principles of plasma transfusion: plasma, cryoprecipitate, albumin, and immunoglobulins. In: Hoffman R, Benz EJ, Silberstein LE, Heslop H, Weltz J, Anstasi J, editors. Hematology: diagnosis and treatment. Philadelphia: Elsevier; 2012. p. 1683–94.

    Google Scholar 

  • Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S–96S.

    Article  CAS  Google Scholar 

  • Kim J, Gearhart MM, Zurick A, et al. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002;53:38–43.

    Article  Google Scholar 

  • Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet. 1999;354:1940–7.

    Article  CAS  Google Scholar 

  • Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus. 2011;9:19–40.

    PubMed  PubMed Central  Google Scholar 

  • Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. Br J Anaesth. 2004;93:842–588.

    Article  CAS  Google Scholar 

  • Mannucci PM. Hemostatic drugs. N Engl J Med. 1998;339:245–53.

    Article  CAS  Google Scholar 

  • Mannucci PM. Intracerebral haemorrhage and recombinant factor VIIa: not so good news! Intern Emerg Med. 2007;2:235–6.

    Article  CAS  Google Scholar 

  • Mannucci PM, Ghirardini A. Desmopressin: twenty years after. Thromb Haemost. 1997;78:958.

    Article  CAS  Google Scholar 

  • Nelson MD, Maeder MA, Usner D, et al. Prevalence and incidence of intracranial hemorrhage in a population of children with haemophilia. The hemophilia growth and development study. Haemophilia. 1999;5:306–12.

    Article  Google Scholar 

  • Norwood SH, McAuley CE, Berne JD, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137:696–702.

    Article  CAS  Google Scholar 

  • Pantanowitz L, Kruskall MS, Uhl L. Cryoprecipitate patterns of use. Am J Clin Pathol. 2003;119:874–81.

    Article  Google Scholar 

  • Praxbind®. Ridgefield: Boehringer Ingelheim Pharmaceuticals; 2015. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761025lbl.pdf.

  • Qureshi AI, Suri MFK. Acute reversal of clopidogrel-related platelet inhibition using methyl prednisolone in a patient with intracranial hemorrhage. Am J Neuroradiol. 2008;29:e97.

    Article  CAS  Google Scholar 

  • Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999;159:2721–4.

    Article  CAS  Google Scholar 

  • Rathbun SW, Whitsett TL, Vesely SK, Raskob GE. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004;125:851–5.

    Article  Google Scholar 

  • Righini M, Le Gal G, Aujesky D, et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet. 2008;371:1343–52.

    Article  Google Scholar 

  • Sachdeva A1, Dalton M, Amaragiri SV, Lees T. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010;7:CD001484.

    Google Scholar 

  • Schaefer JK, McBane RD, Wysokinski WE. How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation. Ann Hematol. 2016;95:437–49.

    Article  CAS  Google Scholar 

  • Schroder WS, Gandhi PJ. Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonist, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents. Curr Cardiol Rep. 2003;5:310–7.

    Article  Google Scholar 

  • Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.

    Article  CAS  Google Scholar 

  • Siegal D, Cuker A. Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis. 2013;35:391–8.

    Article  CAS  Google Scholar 

  • Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth. 2000;85:487–91.

    Article  CAS  Google Scholar 

  • Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589–602.

    Article  Google Scholar 

  • Stein PD, Beemath A, Matta F, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med. 2007a;120:871–9.

    Article  Google Scholar 

  • Stein PD, Alnas M, Beemath A, Patel NR. Outcome of pulmonary embolectomy. Am J Cardiol. 2007b;99:421–3.

    Article  Google Scholar 

  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.

    Article  Google Scholar 

  • van Belle A, Büller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006;295:172–9.

    Article  Google Scholar 

  • Van Berkel MA, Crannage AJ, Murphy JA. Evaluation of education on the appropriate use of vitamin k in warfarin reversal in adult inpatients. Hosp Pharm. 2013;48(8):662–7.

    Article  Google Scholar 

  • van Rossum AB, van Houwelingen HC, Kieft GJ, Pattynama PM. Prevalence of deep vein thrombosis in suspected and proven pulmonary embolism: a meta-analysis. Br J Radiol. 1998;71:1260–5.

    Article  Google Scholar 

  • Van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A. Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103(6):1116–27.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Hematology, Rush University Medical Center, Chicago, IL, USA

    Irene Dehghan-Paz

  2. Division of Stroke and Neurocritical Care, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Thomas P. Bleck

  3. PeaceHealth Southwest Medical Center, Vancouver, WA, USA

    Sarice L. Bassin

Authors
  1. Irene Dehghan-Paz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas P. Bleck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarice L. Bassin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irene Dehghan-Paz .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA

    Ansgar M. Brambrink

  2. Department of Anesthesiology, Oregon Health & Science University, Portland, OR, USA

    Jeffrey R. Kirsch

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dehghan-Paz, I., Bleck, T.P., Bassin, S.L. (2020). Coagulation Management in Neurosurgical Critical Care. In: Brambrink, A., Kirsch, J. (eds) Essentials of Neurosurgical Anesthesia & Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-17410-1_92

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17410-1_92

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17408-8

  • Online ISBN: 978-3-030-17410-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation